Individualized clinical management of patients at risk for Alzheimer's dementia
Open accessThe DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Abstract
Introduction: Multidomain intervention for Alzheimer's disease (AD) risk reduction is an emerging therapeutic paradigm. Methods: Patients were prescribed individually tailored interventions (education/pharmacologic/nonpharmacologic) and rated on compliance. Normal cognition/subjective cognitive decline/preclinical AD was classified as Prevention. Mild cognitive impairment due to AD/mild‐AD was classified as Early Treatment. Change from baseline to 18 months on the modified Alzheimer's Prevention Cognitive Composite (primary outcome) was compared against matched historical control cohorts. Cognitive aging composite (CogAging), AD/cardiovascular risk scales, and serum biomarkers were secondary outcomes. Results: One hundred seventy‐four were assigned interventions (age 25–86). Higher‐compliance Prevention improved more than both historical cohorts (P = .0012, P < .0001). Lower‐compliance Prevention also improved more than both historical cohorts (P = .0088, P < .0055). Higher‐compliance Early Treatment improved more than lower compliance (P = .0007). Higher‐compliance Early Treatment improved more than historical cohorts (P < .0001, P = .0428). Lower‐compliance Early Treatment did not differ (P = .9820, P = .1115). Similar effects occurred for CogAging. AD/cardiovascular risk scales and serum biomarkers improved. Discussion: Individualized multidomain interventions may improve cognition and reduce AD/cardiovascular risk scores in patients at‐risk for AD dementia.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease
Jack, C. R., Bennett, D. A., Blennow, K., Carrillo, M. C., Dunn, B., Haeberlein, S. B., Holtzman, D. M., Jagust, W., Jessen, F., Karlawish, J., et al. (2018) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2018.02.018 · Cited by 10,537
Dementia prevention, intervention, and care
Livingston, G., Sommerlad, A., Orgeta, V., Costafreda, S. G., Huntley, J., Ames, D., Ballard, C., Banerjee, S., Burns, A., Cohen-Mansfield, J., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)31363-6 · Cited by 6,072
Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade
Jack, C. R., Knopman, D. S., Jagust, W. J., Shaw, L. M., Aisen, P. S., Weiner, M. W., Petersen, R. C., & Trojanowski, J. Q. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70299-6 · Cited by 4,806
Jack, C. R., Knopman, D. S., Jagust, W. J., Petersen, R. C., Weiner, M. W., Aisen, P. S., Shaw, L. M., Vemuri, P., Wiste, H. J., Weigand, S. D., et al. (2013) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70291-0 · Cited by 4,396
Ngandu, T., Lehtisalo, J., Solomon, A., Levälahti, E., Ahtiluoto, S., Antikainen, R., Bäckman, L., Hänninen, T., Jula, A., Laatikainen, T., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(15)60461-5 · Cited by 3,689 · cited 1×
“The Finnish Geriatric Intervention Study to Prevent Cognitive Impairment and Disability (FINGER) study was the first large long-term randomized controlled trial (RCT) showing multidomain interventions (nutrition/physical activity/cognitive training) can maintain cognitive function and reduce the risk of cognitive impa…”
The Impact of Age on Cognition
Murman, D. (2015) · Seminars in Hearing · doi:10.1055/s-0035-1555115 · Cited by 1,619 · cited 1×
“, synaptic plasticity, alterations in neuronal structure, dysfunction of neuronal networks) [43].”
Knopman, D. S., DeKosky, S. T., Cummings, J. L., Chui, H., Corey–Bloom, J., Relkin, N., Small, G. W., Miller, B., & Stevens, J. C. (2001) · Neurology · doi:10.1212/wnl.56.9.1143 · Cited by 1,410 · cited 1×
“Additional assessments were ordered in symptomatic patients (incorporating American Academy of Neurology Guidelines [25]), when indicated.”
Religious Orders Study and Rush Memory and Aging Project
Bennett, D. A., Buchman, A. S., Boyle, P. A., Barnes, L. L., Wilson, R. S., & Schneider, J. A. (2018) · Journal of Alzheimer's Disease · doi:10.3233/jad-179939 · Cited by 1,260
Placebo interventions for all clinical conditions
Hróbjartsson, A., & Gøtzsche, P. C. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003974.pub3 · Cited by 777
Validation of the Atherosclerotic Cardiovascular Disease Pooled Cohort Risk Equations
Muntner, P., Colantonio, L. D., Cushman, M., Goff, D. C., Howard, G., Howard, V. J., Kissela, B., Levitan, E. B., Lloyd-Jones, D. M., & Safford, M. M. (2014) · JAMA · doi:10.1001/jama.2014.2630 · Cited by 603
Cited by
Diagnosis of Early Alzheimer's Disease: Clinical Practice in 2021
Porsteinsson, A. P., Isaacson, R. S., Knox, S., Sabbagh, M. N., & Rubino, I. (2021) · The Journal of Prevention of Alzheimer's Disease · doi:10.14283/jpad.2021.23 · Cited by 744
“Following AD diagnosis, a comprehensive approach toward clinical care can be individualized based on the patient’s specific AD risk factors (20, 21).”
Self-citationThe effect of adherence on cognition in a multidomain lifestyle intervention (FINGER)
Ngandu, T., Lehtisalo, J., Korkki, S., Solomon, A., Coley, N., Antikainen, R., Bäckman, L., Hänninen, T., Lindström, J., Laatikainen, T., et al. (2022) · Alzheimer's & Dementia · doi:10.1002/alz.12492 · Cited by 101
Primary prevention recommendations to reduce the risk of cognitive decline
Sabbagh, M. N., Perez, A., Holland, T. M., Boustani, M., Peabody, S. R., Yaffe, K., Bruno, M., Paulsen, R., O'Brien, K., Wahid, N., et al. (2022) · Alzheimer's & Dementia · doi:10.1002/alz.12535 · Cited by 60
Saif, N., Yan, P., Niotis, K., Scheyer, O., Rahman, A., Berkowitz, M., Krikorian, R., Hristov, H., Sadek, G., Bellara, S., et al. (2020) · The Journal of Prevention of Alzheimer's Disease · doi:10.14283/jpad.2019.39 · Cited by 41
Self-citation
Metadata
- Authors
- Isaacson, R. S., Hristov, H., Saif, N., Hackett, K., Hendrix, S., Melendez, J., Safdieh, J., Fink, M., Thambisetty, M., Sadek, G., Bellara, S., Lee, P., Berkowitz, C., Rahman, A., Meléndez‐Cabrero, J., Caesar, E., Cohen, R., Lu, P., Dickson, S. P., Hwang, M. J., Scheyer, O., Mureb, M., Schelke, M. W., Niotis, K., Greer, C. E., Attia, P., Mosconi, L., & Krikorian, R.
- Venue
- Alzheimer's & Dementia
- Publisher
- Wiley
- Published
- 2019-10-30
- Volume
- 15
- Issue
- 12
- Pages
- 1588-1602
- ISSN
- 1552-5260 (ISSN-L)
- 1552-5279
- OpenAlex
- W2982498870
- Cited by
- 76
- References
- 18
- FWCI
- 6.33
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Individualized clinical management of patients at risk for Alzheimer's dementia. https://app.cochat.ai/papers/10.1016/j.jalz.2019.08.198
- The paper
- Isaacson, R. S., Hristov, H., Saif, N., Hackett, K., Hendrix, S., Melendez, J., Safdieh, J., Fink, M., Thambisetty, M., Sadek, G., Bellara, S., Lee, P., Berkowitz, C., Rahman, A., Meléndez‐Cabrero, J., Caesar, E., Cohen, R., Lu, P., Dickson, S. P., . . . Krikorian, R. (2019). Individualized clinical management of patients at risk for Alzheimer's dementia. Alzheimer's & Dementia. https://doi.org/10.1016/j.jalz.2019.08.198
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.